Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China · Delayed Price · Currency is CNY 14.86
+0.05 (0.34%)
Feb 3, 2026, 3:04 PM CST
Chongqing Pharscin Pharmaceutical Company Description
Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China.
The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections.
It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases.
Chongqing Pharscin Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Chongqing, China.
Chongqing Pharscin Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1996 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,384 |
| CEO | Xiaoying Liu |
Contact Details
Address: No. 89, Middle Section of Huangshan Avenue Chongqing, 401120 China | |
| Phone | 86 23 6762 2999 |
| Website | pharscin.com |
Stock Details
| Ticker Symbol | 002907 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003308 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Xiaoying Liu | Chief Executive Officer, GM and Director |
| Xiaoyan Peng | Accounting Supervisor and Chief Financial Officer |
| Ying Wang | Head of Phramaceutical Sales, Deputy GM and Director |
| Xue Dan You | Deputy GM, Secretary of the Board and Non-Independent Director |
| Yong Lu Hang | Chief Operating Officer and Deputy GM |
| Lie Chun Chen | Chief Technology Officer |
| Xu Jun | Securities Affairs Representative |
| Jie Huang | Deputy General Manager |
| Ge Lei | Securities Affairs Representative |